These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31239053)

  • 21. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
    Yang M
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated Design of Macrocycles for Therapeutic Applications: From Small Molecules to Peptides and Proteins.
    Sindhikara D; Wagner M; Gkeka P; Güssregen S; Tiwari G; Hessler G; Yapici E; Li Z; Evers A
    J Med Chem; 2020 Oct; 63(20):12100-12115. PubMed ID: 33017535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges in the design of insulin and relaxin/insulin-like peptide mimetics.
    Hossain MA; Bathgate RAD
    Bioorg Med Chem; 2018 Jun; 26(10):2827-2841. PubMed ID: 28988628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the HIV trans-activation responsive region--approaches towards RNA-binding drugs.
    Krebs A; Ludwig V; Boden O; Göbel MW
    Chembiochem; 2003 Oct; 4(10):972-8. PubMed ID: 14523913
    [No Abstract]   [Full Text] [Related]  

  • 25. New Frontiers in Druggability.
    Kozakov D; Hall DR; Napoleon RL; Yueh C; Whitty A; Vajda S
    J Med Chem; 2015 Dec; 58(23):9063-88. PubMed ID: 26230724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble.
    Stelzer AC; Frank AT; Kratz JD; Swanson MD; Gonzalez-Hernandez MJ; Lee J; Andricioaei I; Markovitz DM; Al-Hashimi HM
    Nat Chem Biol; 2011 Jun; 7(8):553-9. PubMed ID: 21706033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and extended activity of triazole-containing macrocyclic protease inhibitors.
    Pehere AD; Pietsch M; Gütschow M; Neilsen PM; Pedersen DS; Nguyen S; Zvarec O; Sykes MJ; Callen DF; Abell AD
    Chemistry; 2013 Jun; 19(24):7975-81. PubMed ID: 23606616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.
    Du Z; Lind KE; James TL
    Chem Biol; 2002 Jun; 9(6):707-12. PubMed ID: 12079782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors.
    Merlino F; Zhou Y; Cai M; Carotenuto A; Yousif AM; Brancaccio D; Di Maro S; Zappavigna S; Limatola A; Novellino E; Grieco P; Hruby VJ
    J Med Chem; 2018 May; 61(9):4263-4269. PubMed ID: 29660981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.
    Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
    Chen S; Chen R; He M; Pang R; Tan Z; Yang M
    Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.
    Lind KE; Du Z; Fujinaga K; Peterlin BM; James TL
    Chem Biol; 2002 Feb; 9(2):185-93. PubMed ID: 11880033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptidomimetic toolbox for drug discovery.
    Lenci E; Trabocchi A
    Chem Soc Rev; 2020 Jun; 49(11):3262-3277. PubMed ID: 32255135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAR RNA recognition by a cyclic peptidomimetic of Tat protein.
    Leeper TC; Athanassiou Z; Dias RL; Robinson JA; Varani G
    Biochemistry; 2005 Sep; 44(37):12362-72. PubMed ID: 16156649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and bioactivities of TAR RNA targeting beta-carboline derivatives based on Tat-TAR interaction.
    Yu X; Lin W; Pang R; Yang M
    Eur J Med Chem; 2005 Sep; 40(9):831-9. PubMed ID: 15925430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interactions and recognition of cyclic peptide mimetics of Tat with HIV-1 TAR RNA: a molecular dynamics simulation study.
    Li CH; Zuo ZC; Su JG; Xu XJ; Wang CX
    J Biomol Struct Dyn; 2013 Mar; 31(3):276-87. PubMed ID: 22943434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular recognition of HIV-1 RNAs with branched peptides.
    Peralta AN; Dai Y; Sherpa C; Le Grice SFJ; Santos WL
    Methods Enzymol; 2019; 623():373-400. PubMed ID: 31239054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of new PNA-based molecules with TAR RNA of HIV-1: molecular modelling and biological evaluation.
    Terreux R; Pairot S; Cabrol-Bass D; Patino N; Condom R
    J Mol Graph Model; 2001; 19(6):579-85, 614-5. PubMed ID: 11552687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
    Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
    Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.
    Murchie AI; Davis B; Isel C; Afshar M; Drysdale MJ; Bower J; Potter AJ; Starkey ID; Swarbrick TM; Mirza S; Prescott CD; Vaglio P; Aboul-ela F; Karn J
    J Mol Biol; 2004 Feb; 336(3):625-38. PubMed ID: 15095977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.